000 01498 a2200373 4500
005 20250516193409.0
264 0 _c20140624
008 201406s 0 0 eng d
022 _a1423-0380
024 7 _a10.1007/s13277-014-1649-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBailón-Moscoso, Natalia
245 0 0 _aDevelopment of anticancer drugs based on the hallmarks of tumor cells.
_h[electronic resource]
260 _bTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
_cMay 2014
300 _a3981-95 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aDrug Discovery
650 0 4 _aGenomic Instability
650 0 4 _aHumans
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aMutation
650 0 4 _aNeoplasm Invasiveness
650 0 4 _aNeoplasm Metastasis
650 0 4 _aNeoplasms
_xgenetics
650 0 4 _aNeovascularization, Pathologic
_xetiology
700 1 _aRomero-Benavides, Juan Carlos
700 1 _aOstrosky-Wegman, Patricia
773 0 _tTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
_gvol. 35
_gno. 5
_gp. 3981-95
856 4 0 _uhttps://doi.org/10.1007/s13277-014-1649-y
_zAvailable from publisher's website
999 _c23491409
_d23491409